药物对比
Methysergide vs Ubrogepant
比较 Methysergide（传统偏头痛预防药，有纤维化风险）与 Ubrogepant（Ubrelvy，CGRP 拮抗剂用于急性偏头痛）。安全性和用途差异很大。
此页面暂无可用的对比维度。
临床背景
This comparison arises when evaluating outdated migraine prophylactics against modern acute CGRP treatments for patients with recurrent attacks.
结论
Ubrogepant is preferred for acute migraines due to better safety, while Methysergide is obsolete with high long-term risks.
全部药物对比